HOME ABOUT US SERVICES RESEARCH EQUITY DERIVATIVES IPO INTERNET TRADING FTP CONTACT US
  
SENSEX -4.30 -0.02%
24326.65
 
NIFTY -114.00 -0.15%
77844.52
 
Nasdaq 512.81 2.02%
25838.94
 
Nikkei 225 228.20 0.38%
59513.12
 
FTSE 100 219.60 2.15%
10438.70
 
YOU ARE ON
Equity
Equity Analysis
Price
Gainers & Losers
Out & Under Performers
Only Buyers & Sellers
Advances & Declines
New Highs & Lows
Weightage
5 Day's Up & Down
Historical Returns
Volume
Analysis
News Analysis
Corporate Action
Corporate Info
Other Market
 
Astonea Labs Ltd.
 
Source DateBoard Meeting DateDetails
24-Feb-2026 27-Feb-2026 Inter alia, to consider and approve, 1) To consider and approve the proposal for variation in the objects of the Initial Public Offer (IPO). 2) To consider and grant omnibus approval for material related party transactions for the financial year 2026-27, in accordance with Section 188 of the Companies Act, 2013 and Regulation 23 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. 3) To consider and approve the adoption of the new set of Articles of Association of the Company. 4) To consider and approve the relocation of the Registered Office of the Company within the same city. 5) To consider and approve the date, time, and venue for convening an Extra-Ordinary General Meeting (?EGM?) to seek shareholders? approval for the matters approved by the Board at this meeting, and to authorize the issuance of the Notice of EGM and other related actions in this regard. 6) To take any other matter with the permission of the Chairman, if any.
28-Nov-2025 03-Dec-2025 A.G.M. & Inter alia, to consider and approve:- 1. To consider and approve the Notice convening the Annual General Meeting (AGM) of the Company for the financial year 2024-25. 2. To review and approve the Directors? Report for the financial year ended 31.03.2025. 3. To approve the appointment of the Company Secretary and Compliance Officer of the Company. 4. To acknowledge and accept the resignation of Mr. Pardeep Singh (DIN: 10345015) , Director of the Company. 5. To consider and approve the acquisition of equity stake in Damaira Pharmaceuticals Private Limited. 6. To consider and approve the relocation/shifting of the Company?s corporate office and authorize the Board to complete all formalities in this regard. 7. To consider and approve the proposal for voluntary transition from AS to Ind AS. 8. To consider and approve the proposal for opening and making investments in multiple foreign subsidiaries/wholly owned subsidiaries. 9. To consider and approve the Policy for Preservation of Documents of the Company
06-Nov-2025 10-Nov-2025 Half Yearly Results
04-Jul-2025 11-Jul-2025 Audited Results Inter alia, to consider and approve:- 1. To consider and approve the Audited Financial Results of the Company for the Financial Year ended 31st March, 2025. 2. To take on record resignation of CS AVNEET KAUR (ACS - 27857) from the post of Company Secretary & Compliance Officer and a Key Managerial Personnel of the Company. 3. To terminate Registrar and Share Transfer Agent Agreement with KFin Technologies Limited. 4. To appoint BEETAL Financial & Computer Services Pvt Ltd. as Registrar and Share Transfer Agent. 5. To approve appointment of Internal Auditors. 6. To approve appointment of Secretarial Auditors. 7. Approval of Related Party Transactions. 8. To consider and approve any other agenda.
Page 1 of 1
Prev || Next
 
ADINATH STOCK BROKING PVT LTD  :   SEBI REGISTRATION NUMBERS : Bombay Stock Exchange(BSE): CASH -INZ000204337 & DERIVATIVE -INZ000204337 Member ID-3175 National Stock Exchange(NSE): CASH- INZ000204337 & DERIVATIVES -INZ000204337 Member ID-12805 MCX-SX Stock Exchange(MCX-SX): Currency Derivative : INZ000204337 Member ID-44400 United Stock Exchange(USE): Currency Derivative: Central Depository Services Ltd(CDSL)- IN -DP-452/2008 DP ID 12055200
ATTENTION INVESTORS :   "Prevent unauthorised transactions in your Broking & demat account--> Update your mobile numbers/email IDs with your stock brokers & depository participate. Receive information of your transactions directly from Exchange & CDSL on your mobile/email at the end of the day......................Issued in the interest of Investors"
ATTENTION INVESTORS :   "KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary."
ATTENTION INVESTORS :   "No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."
ATTENTION INVESTORS :   1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. "Issued in the interest of Investors"
| Disclaimer | Privacy Policy | Feedback | Terms and Conditions | Careers | Investor Grievances | Download | Investor Protection | SCORES | Site Map
Investor Charter - DP | Investor Charter - Stock Broker | e-voting | Investor Education | Client Collateral Details | NSDL eVoting | Advisory for investors
Useful links: NSE | BSE | MCX-SX | CDSL | SEBI | MCX | NCDEX | FMC | Smart ODR
SEBI Registration No.INZ000042629
Copyright © 2011 Adinath Stock Broking Pvt Ltd                             Designed, Developed & Content Powered By ●●● Accord Fintech Pvt.Ltd.